Doctor profile · Federal record
Dr. Michael Musci, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Mesa, AZ
- NPI 1942388442
- Accepts Medicare
- MIPS 93.6 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6111 E Arbor Ave
Mesa, AZ 852066059
(480) 981-1326
fax (480) 981-1445 - Mailing address
-
Po Box 6423
Chandler, AZ 852466423
Credentials & registration
- NPI registered
- November 2006 — 20 yrs on file
- Profile last updated
- November 17, 2022
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Arizona #36785
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1942388442. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
50,595
Distinct HCPCS
10
Medicare allowed
$422,588
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 23,250 | 19 | $1 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 16,775 | 136 | $0 | |
J1453 |
Injection, fosaprepitant, 1 mg | 2,550 | 12 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,632 | 37 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,120 | 33 | $1 | |
J0640 |
Injection, leucovorin calcium, per 50 mg | 699 | 11 | $4 | |
J9190 |
Injection, fluorouracil, 500 mg | 478 | 11 | $2 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 455 | 247 | $87 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 440 | 16 | $0 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 234 | 57 | $125 |
In context: peer comparison
Among 3 peers in Mesa Hematology & Oncology Physician, average services per provider: 1,776. This provider delivers 28× the peer median.Open Payments
Industry payments received
All-time total
$2,388
Transactions
87
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 13 | $307.69 | |
| Novartis Pharmaceuticals Corporation | 12 | $265.38 | |
| Pfizer INC. | 14 | $242.55 | |
| Genmab U.S., INC. | 6 | $164.45 | |
| Abbvie INC. | 7 | $163.99 | |
| Merck Sharp & Dohme LLC | 8 | $133.81 | |
| Janssen Biotech, INC. | 4 | $83.43 | |
| Sumitomo Pharma America, INC. | 3 | $81.36 | |
| Daiichi Sankyo INC. | 3 | $73.65 | |
| Eisai INC. | 3 | $71.06 | |
| Astellas Pharma US INC | 3 | $64.29 | |
| BeiGene USA, INC. | 3 | $61.94 | |
| Rigel Pharmaceuticals, INC. | 2 | $60.15 | |
| Incyte Corporation | 3 | $56.06 | |
| Celgene Corporation | 3 | $52.53 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
708
Patients
225
Total drug cost
$1,218,182
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 119 | 21 | $88,731 |
| Anastrozole | Generic | 81 | 21 | $2,402 |
| Ondansetron Odt (Ondansetron) | Brand | 72 | 53 | $1,452 |
| Acyclovir | Generic | 71 | 23 | $1,451 |
| Dexamethasone | Generic | 68 | 43 | $1,705 |
| Prochlorperazine Maleate | Generic | 53 | 40 | $1,283 |
| Hydroxyurea | Generic | 50 | 12 | $1,808 |
| Prednisone | Generic | 32 | 12 | $216 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 28 | 0 | $264,204 |
| Imatinib Mesylate | Generic | 26 | 0 | $17,393 |
Hospital affiliations
Frequently asked questions
What is Dr. Michael Musci's medical specialty?
Dr. Michael Musci practices Hematology & Oncology Physician in Mesa, AZ.
Where does Dr. Michael Musci practice?
Dr. Michael Musci practices at 6111 E Arbor Ave, Mesa, AZ 852066059. Office phone: 4809811326.
What is Dr. Michael Musci's NPI?
Dr. Michael Musci's National Provider Identifier (NPI) is 1942388442, issued by NPPES.
Does Dr. Michael Musci accept Medicare assignment?
Yes. Dr. Michael Musci accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Musci commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS Q9967); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.